Listen on Spotify, Apple Podcasts, or search “Devex” in your favorite podcast app.
Last week, the U.S. Agency for International Development unveiled its latest $5 billion global health supply contract, part of its NextGen suite of contracts. Worth $17 billion in total, it’s the largest suite of foreign aid contracts ever issued, to be delivered over the course of 10 years. But despite all the talk around localization, it’s highly likely the contracts will end up going to the usual industry players.
“Most of the low- or middle-income countries, they can do without those USAID-funded contractors coming to do things for them,” said Olusoji Adeyi, president of Resilient Health Systems and a staunch advocate for the decolonization of the sector.
The previous iteration of USAID’s global health supply contract, worth $9.5 billion and delivered solely through Chemonics, failed to live up to expectations after running into multiple delays and performance problems. “USAID has refused to learn, and they are throwing $17 billion of taxpayer money after a failed business model,” said Adeyi.
Listen to the latest episode of This Week in Global Development to hear Adeyi discuss this topic and the other big stories from the week with Devex President and Editor-in-Chief Raj Kumar and Managing Editor Anna Gawel.
Sign up to the Devex Newswire and our other newsletters.
About the author
Naomi Mihara
Naomi Mihara is an Associate Editor for Devex, working on creative and audiovisual projects. She has a background in journalism and international development, having previously served as an assistant correspondent for Japanese newspaper The Yomiuri Shimbun and as a communications officer for the International Organization for Migration in Southeast Asia. She holds a master’s degree in Multimedia Journalism from Bournemouth University.
